- Home
- CLDI vs IFBD Comparison
CLDI vs IFBD Comparison
Compare CLDI & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- IFBD
- Stock Information
- Founded
- CLDI 2014
- IFBD 2001
- Country
- CLDI United States
- IFBD China
- Employees
- CLDI N/A
- IFBD N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- IFBD Computer Software: Prepackaged Software
- Sector
- CLDI Health Care
- IFBD Technology
- Exchange
- CLDI Nasdaq
- IFBD Nasdaq
- Market Cap
- CLDI 8.7M
- IFBD 8.4M
- IPO Year
- CLDI N/A
- IFBD 2021
- Fundamental
- Price
- CLDI $1.60
- IFBD $1.10
- Analyst Decision
- CLDI
- IFBD
- Analyst Count
- CLDI 0
- IFBD 0
- Target Price
- CLDI N/A
- IFBD N/A
- AVG Volume (30 Days)
- CLDI 141.6K
- IFBD 133.7K
- Earning Date
- CLDI 11-11-2025
- IFBD 05-01-2023
- Dividend Yield
- CLDI N/A
- IFBD N/A
- EPS Growth
- CLDI N/A
- IFBD N/A
- EPS
- CLDI N/A
- IFBD N/A
- Revenue
- CLDI N/A
- IFBD $4,861,442.00
- Revenue This Year
- CLDI N/A
- IFBD N/A
- Revenue Next Year
- CLDI N/A
- IFBD N/A
- P/E Ratio
- CLDI N/A
- IFBD N/A
- Revenue Growth
- CLDI N/A
- IFBD 1520.48
- 52 Week Low
- CLDI $1.41
- IFBD $0.89
- 52 Week High
- CLDI $46.68
- IFBD $3.32
- Technical
- Relative Strength Index (RSI)
- CLDI 43.90
- IFBD 46.82
- Support Level
- CLDI $1.41
- IFBD $1.00
- Resistance Level
- CLDI $1.68
- IFBD $1.10
- Average True Range (ATR)
- CLDI 0.08
- IFBD 0.10
- MACD
- CLDI 0.05
- IFBD -0.02
- Stochastic Oscillator
- CLDI 66.74
- IFBD 15.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.